Prolonged thromboprophylaxis with low molecular weight heparin after major abdominal surgery

Current Opinion in Pulmonary Medicine

Volumn 13, Issue 5, 2007, Pages 389-392

  Rasmussen, Morten S ^a  

^a BISPEBJERG HOSPITAL   (Denmark)

Author keywords

Abdominal surgery; Low molecular weight heparin; Prolonged; Thromboprophylaxis

Indexed keywords

DALTEPARIN; ENOXAPARIN; LOW MOLECULAR WEIGHT HEPARIN; PLACEBO; TINZAPARIN;

ABDOMINAL SURGERY; BLEEDING; CLINICAL PROTOCOL; CLINICAL TRIAL; DEEP VEIN THROMBOSIS; DRUG EFFICACY; DRUG SAFETY; HUMAN; LONG TERM CARE; LUNG EMBOLISM; MAJOR SURGERY; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; REVIEW; THROMBOSIS PREVENTION; TREATMENT INDICATION;

ABDOMEN; ANTICOAGULANTS; DOSE-RESPONSE RELATIONSHIP, DRUG; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; POSTOPERATIVE COMPLICATIONS; TIME FACTORS; VENOUS THROMBOSIS;

EID: 34748866073     PISSN: 10705287     EISSN: 15316971     Source Type: Journal    
DOI: 10.1097/MCP.0b013e3282058ba6     Document Type: Review

References (15)

1. Geerts WH, Pineo GF, Heit JA, et al. Prevention of venous thromboembolism. Chest 2004; 126:338S-400S.
2. Iversen LH, Thorlacius-Ussing O. Relationship of coagulation test abnormalities to tumour burden and postoperative DVT in resected colorectal cancer. Thromb Haemost 2002; 87:402-408.
3. Dahl OE, Aspelin T, Arnesen H, et al. Increased activation of coagulation and formation of late deep venous thrombosis following discontinuation of thromboprophylaxis after hip replacement surgery. Thromb Res 1995; 80:299-306.
4. Arnesen H, Dahl OE, Aspelin T, et al. Sustained prothrombotic profile after hip replacement surgery: the influence of prolonged prophylaxis with dalteparin. J Thromb Haemost 2003; 1:971-975.
5. Hull RD, Pineo GF, Stein PD, et al. Extended out-of-hospital low-molecular-weight heparin prophylaxis against deep venous thrombosis in patients after elective hip arthroplasty: a systematic review. Ann Intern Med 2001; 135: 858-869.
6. Eikelboom JW, Quinlan DJ, Douketis JD. Extended-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of the randomised trials. Lancet 2001; 358:9-15.
7. Galster H, Kolb G, Kohsytorz A, et al. The pre, peri, and postsurgical activation of coagulation and the thromboembolic risk for different risk groups. Thromb Res 2000; 100:381-388.
8. Scurr JH, Coleridge-Smith PD, Hasty JH. Deep venous thrombosis: a continuing problem. Br Med J 1988; 297:28.
9. Sørensen C, Andersen M, Kristiasen VB, et al. The occurrence of late thromboembolic complications after elective abdominal surgery [in Danish]. Ugeskr Laeger 1990; 152:1586-1587.
10. Kiil J, Kiil J, Axelsen F, Andersen D. Prophylaxis against postoperative pulmonary embolism and deep-vein thrombosis by low-dose heparin. Lancet 1978; 1:1115-1116.
11. Huber O, Bounameaux H, Borst F, Rohner A. Postoperative pulmonary embolism after hospital discharge. An underestimated risk. Arch Surg 1992; 127:310-313.
12. Lausen I, Jensen R, Jorgensen LN, et al. Incidence and prevention of deep venous thrombosis occurring late after general surgery: randomised controlled study of prolonged thromboprophylaxis. Eur J Surg 1998; 164:657-663.
13. Bergqvist D, Agnelli G, Cohen AT, et al. Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer. N Engl J Med 2002; 346:975-980.
14. Rasmussen MS, Jorgensen LN, Wille-Jørgensen P, et al. Prolonged prophylaxis with dalteparin to prevent late thromboembolic complications in patients undergoing major abdominal surgery: a mulitcenter randomized open-label study. J Thromb Haemost 2006; 4:2384-2390. This paper is the largest study dealing with prolonged thromboprophylaxis after abdominal surgery, including general surgery patients without selection.
15. SAGES Guideline Committee. Guidelines for deep venous thrombosis prophylaxis during laparoscopic surgery. Surg End 2007; April 5 [Epub ahead of print].